Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Low-dose daclatasvir and Olysio (simeprevir) cured a relatively high proportion of people with genotype 1b of hepatitis C, but just two thirds...
Sovaldi and ribavirin cured 75 percent of those with genotype 1 of hepatitis C in a recent trial, while treatment-naive people with genotype 3...
Twelve weeks of daclatasvir, asunaprevir and BMS-791325 cured more than 90% of treatment-naive people with genotype 1 of hepatitis C.
Early results of Merck’s combination hepatitis C therapy showed comparable safety between those with or without HIV, plus near-perfect cure ra...
Six weeks of the combination pill of ledipasvir and Sovaldi, with or without GS-9669 or GS-9451, cured 95 to 100 percent of people with hep C...
AbbVie’s investigational triple-combination therapy cured close to 100 percent of people with genotype 1b.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.